Pharmaceutical Companies

Trump’s Promise to Cut Drug Prices Turns Into Another Ploy to Enrich Industry, Blame Foreigners

Trump promised to rein in drug prices. It was his only sensible campaign promise.
But the plan he announced Friday does little but add another battering ram to his ongoing economic war against America’s allies.
He calls it “American patients first,” and takes aim at what he calls “foreign freeloading.” The plan will pressure foreign countries to relax their drug price controls.

Congress Prepares to Vote on Bill That Would Speed up Drug Approval

Congress will vote today on a nearly 1,000-page bill that holds drastic changes for the U.S. Food and Drug Administration (FDA). If the bill is approved, it would speed up the approval of new drugs and medical devices. The House has been heavily criticized for allegedly rushing piece of legislation through without sufficient scrutiny. [1]
Source: National Center for Health Research

World Leaders Meet to Finally Address Antibiotic Resistance Crisis

On September 21, the United Nations (UN) General Assembly passed a declaration aimed at slowing the spread of antibiotic-resistant superbugs, calling it “historical” and “a turning point.”
The World Health Organization’s (WHO) Dr. Keiji Fukada said:

“I think the declaration will have very strong implications. What it will convey is that there’s recognition that we have a big problem and there’s a commitment to do something about it.”